The senator sent a letter to Alkermes CEO Richard Pops requesting more information on the company's tactics for promoting and distributing Vivitrol.

NPR and Side Effects Public Media have identified at least eight courts out of the several dozen in Indiana that say they only allow a treatment from drugmaker Alkermes.

Some Indiana lawmakers are responding to a Side Effects Public Media and NPR report detailing how the president of an Indiana nonprofit is also lobbying for a drug company.

An investigation by NPR and WFYI's public health news service, Side Effects Public Media, found that in statehouses across the country, and in Congress, drugmaker Alkermes is pushing its addiction treatment drug, Vivitrol, while contributing to misconceptions and stigma about other medications used to treat opioid addiction.

Health and Human Services Secretary Tom Price, referred to medication-assisted treatment for addiction as "substituting one opioid for another."

A bill to help combat the opioid epidemic in Indiana is making its way to the governor's desk.